Cabergoline administration prevents development of moderate to severe ovarian hyperstimulation syndrome and it contributes to reduction in ovarian volume

Conclusions Cabergoline has a favorable effect on the prevention of moderate to severe OHSS affiliated with ovarian volume reduction.
Source: Reproductive Medicine and Biology - Category: OBGYN Source Type: research
More News: Biology | Hormones | OBGYN | Ovaries | Study | Women